SLC12A5 and Alzheimer disease: Mouse models carrying AD-related mutations show pre-symptomatic loss of the neuronal K+–Cl− cotransporter KCC2 in hippocampus and prefrontal cortex, weakeningGABAergic inhibition and disturbing Cl− balance.